{"schema_version":"secwatch.filing_event.v1","accession":"0001588978-25-000041","form_type":"8-K","ticker":"PRCT","cik":"0001588978","company_name":"PROCEPT BioRobotics Corp","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.442087+00:00","generated_at":"2026-05-17T19:27:57.160072+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PROCEPT Q2 revenue $79.2M (+48% YoY); raises FY25 guidance; appoints new CEO","bullets":["Q2 total revenue $79.2M, up 48% YoY; U.S. handpiece/consumables $43.1M (+58%).","Net loss improved to $19.6M from $25.6M; Adjusted EBITDA loss $8.0M (vs. $17.9M loss prior year).","Gross margin expanded to 65% from 59% due to operational efficiencies and higher system ASP.","Raises FY 2025 revenue guidance to $325.5M (45% growth) from prior $323.0M; expects 64.5% gross margin.","Appoints Larry Wood as CEO effective Sept. 2, 2025; brings 40 years medtech leadership."],"urls":{"canonical":"https://secwatch.observer/filing/0001588978-25-000041","json":"https://secwatch.observer/filing/0001588978-25-000041.json","markdown":"https://secwatch.observer/filing/0001588978-25-000041.md","text":"https://secwatch.observer/filing/0001588978-25-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1588978/000158897825000041/0001588978-25-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1588978/000158897825000041/prct-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:27:57.160072+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}